标题
Interferon resistance of emerging SARS-CoV-2 variants
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 32, Pages -
出版商
Proceedings of the National Academy of Sciences
发表日期
2022-07-23
DOI
10.1073/pnas.2203760119
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Omicron’s feeble attack on the lungs could make it less dangerous
- (2022) Max Kozlov NATURE
- Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
- (2022) Jonas Schuhenn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specialized interferon action in COVID-19
- (2022) Matthew D. Galbraith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
- (2021) Marcos V. P. Gondim et al. Science Translational Medicine
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- S-variant SARS-CoV-2 lineage B1.1.7 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-qPCR
- (2021) Michael Kidd et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Functional landscape of SARS-CoV-2 cellular restriction
- (2021) Laura Martin-Sancho et al. MOLECULAR CELL
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
- (2021) Nicholas G. Davies et al. NATURE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- The interferon landscape along the respiratory tract impacts the severity of COVID-19
- (2021) Benedetta Sposito et al. CELL
- The origins of SARS-CoV-2: A critical review
- (2021) Edward C. Holmes et al. CELL
- Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)
- (2021) Sean Wei Xiang Ong et al. CLINICAL INFECTIOUS DISEASES
- The biological and clinical significance of emerging SARS-CoV-2 variants
- (2021) Kaiming Tao et al. NATURE REVIEWS GENETICS
- Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
- (2021) Catherine M. Brown et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Dissecting the early COVID-19 cases in Wuhan
- (2021) Michael Worobey SCIENCE
- Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
- (2021) Andre C Kalil et al. Lancet Respiratory Medicine
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Interferon beta-1b for COVID-19
- (2020) Sarah Shalhoub LANCET
- Introductions and early spread of SARS-CoV-2 in the New York City area
- (2020) Ana S. Gonzalez-Reiche et al. SCIENCE
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- (2020) Bette Korber et al. CELL
- Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
- (2020) Nan Wang et al. Cell Host & Microbe
- Inhibition of SARS-CoV-2 by type I and type III interferons
- (2020) Ulrike Felgenhauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
- (2020) Abigail Vanderheiden et al. JOURNAL OF VIROLOGY
- Activation and evasion of type I interferon responses by SARS-CoV-2
- (2020) Xiaobo Lei et al. Nature Communications
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
- (2020) Andrew Rambaut et al. Nature Microbiology
- Spike mutation D614G alters SARS-CoV-2 fitness
- (2020) Jessica A. Plante et al. NATURE
- The emergence of SARS-CoV-2 in Europe and North America
- (2020) Michael Worobey et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans
- (2020) Rayhane Nchioua et al. mBio
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis
- (2020) Kejun Guo et al. PLoS Pathogens
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects
- (2019) Erika Schlaepfer et al. mSphere
- IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
- (2019) Rudragouda Channappanavar et al. JOURNAL OF CLINICAL INVESTIGATION
- Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness
- (2017) Shilpa S. Iyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
- (2016) Sophia Davidson et al. EMBO Molecular Medicine
- Interferon Alpha Subtype-Specific Suppression of HIV-1 InfectionIn Vivo
- (2016) Kerry J. Lavender et al. JOURNAL OF VIROLOGY
- Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection
- (2015) Cherie T. Ng et al. Cell Host & Microbe
- Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms
- (2015) Michael S. Harper et al. PLoS Pathogens
- IFN-α subtypes: distinct biological activities in anti-viral therapy
- (2012) K Gibbert et al. BRITISH JOURNAL OF PHARMACOLOGY
- Binding and activity of all human alpha interferon subtypes
- (2011) Thomas B. Lavoie et al. CYTOKINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now